β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease – A Danish Nationwide Study of 1·3 Million Individuals

BACKGROUND: The possible association between β-adrenoceptor antagonists (β-blockers) and risk of COPD is controversial. The objective of the present study was to test whether β-blocker use is associated with susceptibility to the disease. METHODS: A total of 301,542 new users of β-blockers and 1,000...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Anne Orholm, Pedersen, Lars, Sode, Birgitte Fischer, Dahl, Morten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537528/
https://www.ncbi.nlm.nih.gov/pubmed/31193622
http://dx.doi.org/10.1016/j.eclinm.2019.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537528/
https://www.ncbi.nlm.nih.gov/pubmed/31193622
http://dx.doi.org/10.1016/j.eclinm.2019.01.004

Ejemplares similares